Evidence map›Paper›PMID 40297444›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Geographical Heterogeneity in Antimalarial Resistance Markers Revealed by Genomic Surveillance in Angola, 2023.

Maria Florinda João, Andrés Aranda-Díaz, Faith De Amaral, Takalani I Makhanthisa, Sonja B Lauterbach, Mukosha Chisenga, Brighton Mangena, Paulo Maquina, Isobel Routledge, Chadwick Sikaala and 6 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Maria Florinda JoãoPrograma Nacional do Controlo da Malária, Luanda, Angola.
Andrés Aranda-DíazEPPIcenter Research Program, Department of Medicine, University of California, San Francisco, United States of America.ORCID 0000-0002-0566-4901
Faith De AmaralEPPIcenter Research Program, Department of Medicine, University of California, San Francisco, United States of America.
Takalani I MakhanthisaLaboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0002-6044-3669
Sonja B LauterbachLaboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0003-4941-9972
Mukosha ChisengaSADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Brighton MangenaSADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Paulo MaquinaSADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Isobel RoutledgeMalaria Elimination Initiative, Global Health Group, University of California, San Francisco, United States of America.ORCID 0000-0002-0354-4076
Chadwick SikaalaSADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
John ChimumbwaSADC Malaria Elimination Eight Secretariat, Windhoek, Namibia.
Domingos JandondoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
José Franco MartinsPrograma Nacional do Controlo da Malária, Luanda, Angola.
Jaishree RamanLaboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.ORCID 0000-0003-0728-3093
Jennifer L SmithMalaria Elimination Initiative, Global Health Group, University of California, San Francisco, United States of America.
Pedro Rafael DimbuPrograma Nacional do Controlo da Malária, Luanda, Angola.

Funding

Genetic and social network analysis to target interventions for malaria eliminationK01AI153555 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SMITH, JENNIFER LINNEA · 2020 to 2024
$725k
Gates Foundation INV-024346NIAID NIH HHS K01 AI153555
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40297444
PMCPMC12036384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.